Evaluation of a Novel Liquid Fiducial Marker, BioXmark<sup>®</sup>, for Small Animal Image-Guided Radiotherapy Applications
BioXmark<sup>®</sup> (Nanovi A/S, Denmark) is a novel fiducial marker based on a liquid, iodine-based and non-metallic formulation. BioXmark<sup>®</sup> has been clinically validated and reverse translated to preclinical models to improve cone-beam CT (CBCT) target delineatio...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-05-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/12/5/1276 |